pegaptanib sodium
A5751010
Phase 3 small_molecule completed
Quick answer
pegaptanib sodium for Macular Degeneration is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Macular Degeneration
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed